METABolic Deterioration in HTX Determines Outcomes
ConditionHeart Transplantation
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHeinrich-Heine University, Duesseldorf
About this trial
METAB-HTX is a prospective, longitudinal cohort study evaluating cardiac and systemic metabolism in heart transplant recipients.
Eligibility criteria
Qualifiers
Age: ≥ 18 years
Planned or already conducted heart transplantation
Informed consent
Disqualifiers
Absence of informed consent
Trial design
Treatments tested in this trial
- Not listed
Trial groups
270 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov